EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial transfer and mesenchymal stem cells in ophthalmology: current evidence and therapeutic implications

Xiaoli Liu, Mingqi Zhang, Zhuoshi Wang

Experimental Biology and Medicine · 30.06.2026 · 251

DOI: 10.3389/ebm.2026.11128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Experimental Biology and Medicine, online erschienen am 30.06.2026. Verfasst von Xiaoli Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Key Lab of Ophthalmic Stem Cells, He University, Shenyang, China. Hauptthemen laut MEDLINE: Mitochondria, Mesenchymal Stem Cells, Eye Diseases, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction, driven by genetic mutations or oxidative stress, is a central contributor to the onset and progression of ophthalmic diseases. In recent years, intercellular mitochondrial transfer (MT) has emerged as a novel mechanism of cellular communication and repair in ocular tissues. MT occurs through tunneling nanotubes, extracellular vesicles (EVs), cell fusion, or transmitophagy, and has been shown to support photoreceptor survival, maintain retinal homeostasis, and protect against oxidative injury. Mesenchymal stem cells (MSCs), owing to their remarkable reparative and immunomodulatory properties, have attracted particular attention as efficient mitochondrial donors. Evidence from experimental models demonstrates that MSC-mediated MT can restore bioenergetics, mitigate oxidative stress, and rescue cellular function in inherited optic neuropathies, corneal injuries, retinal degenerative diseases, and ischemic retinopathies. This review summarizes current evidence of MT in ophthalmology, highlights the therapeutic contributions of MSCs, discusses the molecular and microenvironmental factors regulating MT efficiency, and outlines unresolved challenges. We further provide perspectives on how mitochondrial transfer may be translated into innovative therapies for ocular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaMesenchymal Stem CellsEye DiseasesMesenchymal Stem Cell TransplantationOphthalmologyHumansAnimalsOxidative Stress

Stichwörter der Autor:innen

clinical translationmesenchymal stem cellsmitochondrial transferophthalmic diseasesretinal degeneration

Autor:innen und Institutionen

  • Liaoning Key Lab of Ophthalmic Stem Cells, He University, Shenyang, China.
  • School of Pharmacy, He University, Shenyang, China.
  • Science and Education Department, He Eye Specialist Hospital, Shenyang, China.

Zitieren

APA

Liu, X., Zhang, M., & Wang, Z. (2026). Mitochondrial transfer and mesenchymal stem cells in ophthalmology: current evidence and therapeutic implications. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.11128

Vancouver

Liu X, Zhang M, Wang Z. Mitochondrial transfer and mesenchymal stem cells in ophthalmology: current evidence and therapeutic implications. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.11128

BibTeX
@article{Liu2026,
  author = {Liu, Xiaoli and Zhang, Mingqi and Wang, Zhuoshi},
  title = {Mitochondrial transfer and mesenchymal stem cells in ophthalmology: current evidence and therapeutic implications},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.11128}
}
Kostenlos starten →